Alan J. Main
2022
In 2022, Alan J. Main earned a total compensation of $1.4M as Executive Vice President, Innovation and Chemical Sciences at Lexicon Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Bonus | $152,457 |
|---|---|
| Option Awards | $580,928 |
| Salary | $426,169 |
| Stock Awards | $246,400 |
| Other | $12,775 |
| Total | $1,418,729 |
Main received $580.9K in option awards, accounting for 41% of the total pay in 2022.
Main also received $152.5K in bonus, $426.2K in salary, $246.4K in stock awards and $12.8K in other compensation.
Rankings
In 2022, Alan J. Main's compensation ranked 2,350th out of 5,760 executives tracked by ExecPay. In other words, Main earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,350 out of 5,760 | 59th |
Division Manufacturing | 1,279 out of 3,136 | 59th |
Major group Chemicals And Allied Products | 571 out of 1,422 | 60th |
Industry group Drugs | 526 out of 1,323 | 60th |
Industry Pharmaceutical Preparations | 380 out of 969 | 61st |
Source: SEC filing on March 26, 2024.
Main's colleagues
We found four more compensation records of executives who worked with Alan J. Main at Lexicon Pharmaceuticals in 2022.
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019